WallStreetZenWallStreetZen

NASDAQ: TRAW
Traws Pharma Inc Stock Ownership - Who owns Traws Pharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Traws Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark Patrick GuerinCFO AND COO2024-03-142,591$0.90
$2.33kSell
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2024-03-148,727$0.90
$7.85kSell
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2024-02-079,212$0.67
$6.17kSell
Mark Patrick GuerinCFO AND COO2024-02-072,443$0.67
$1.64kSell
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2023-08-034,744$1.01
$4.79kSell
Mark Patrick GuerinCFO AND COO2023-08-031,422$1.02
$1.45kSell
Mark Patrick GuerinCFO AND COO2023-06-121,575$1.14
$1.79kSell

1 of 1

TRAW insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRAW insiders and whales buy or sell their stock.

TRAW Shareholders

What type of owners hold Traws Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman32.85%6,911,786$4.29MInsider
Jane Hoffman 2013 Descendants Michael21.47%4,518,275$2.81MInsider
Nikolay Savchuk12.67%2,664,819$1.65MInsider
Gmbh Baxalta12.37%2,603,295$1.62MInsider
Iain D. Dukes8.46%1,779,287$1.10MInsider
Armistice Capital LLC7.86%1,653,902$1.03MInsider
Viriom Inc7.82%1,645,100$1.02MInsider
Tpav LLC5.81%1,222,738$759.32kInsider
Orbimed Advisors LLC4.97%1,045,261$649.11kInsider
Vanguard Group Inc3.37%708,618$440.05kInstitution

1 of 3

TRAW vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRAW5.95%94.05%Net SellingNet Selling
NNVC2.27%97.73%
XTLB0.04%20.78%
SNTI25.05%52.51%
MIRA0.66%30.26%Net Buying
View Top Biotech Stocks

Traws Pharma Stock Ownership FAQ

Who owns Traws Pharma?

Traws Pharma (NASDAQ: TRAW) is owned by 7.93% institutional shareholders, 125.44% Traws Pharma insiders, and 0.00% retail investors. Michael B. Hoffman is the largest individual Traws Pharma shareholder, owning 6.91M shares representing 32.85% of the company. Michael B. Hoffman's Traws Pharma shares are currently valued at $4.29M.

If you're new to stock investing, here's how to buy Traws Pharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.